Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Fermer

Transgene and Hypertrust Patient Data Care announce successful go-live of the world's first blockchain solution for clinical trials of personalized healthcare
information fournie par Boursorama CP 09/07/2020 à 08:30

Strasbourg (FR) / Munich (DE) - July 9, 2020 - 8:30 am CET -Transgene and Hypertrust Patient Data Care today announced as a world premiere the first productive blockchain solution for clinical trials of personalized healthcare, leveraging the Hypertrust X-Chain for Clinical Trials product. The cloud-based solution monitors and orchestrates the supply chain processes of Transgene's AI-enhanced TG4050 individualized therapeutic vaccine based on the myvac® technology, against ovarian, head and neck cancer providing an immutable audit trail throughout the treatment process.

The innovative collaboration between Transgene and Hypertrust marks a milestone in the ongoing fight against cancer. The blockchain-based Hypertrust X-Chain solution supports Transgene's personalized immunotherapies comprehensively, ensuring a trustworthy process in the background of the medical treatment. All emerging personalized treatments have a massive need for trustworthy and decentralized solutions, due to the strong cross-company collaborative nature of the production process.

.../...

Valeurs associées

0,6060 EUR Euronext Paris +0,33%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

Cette liste ne contient aucune valeur.